Clinical Study Results
?
1. Study Name
Title of the Study: A Dose-ranging, Double-blind, Placebo-controlled Study to
Evaluate the Safety and Efficacy of Tezepelumab Alone or
Combined With Topical Corticosteroids in Moderate-to-
Severe Atopic Dermatitis
Brief Title: A Dose-ranging, Double-blind, Placebo-controlled Study to
Evaluate the Safety and Efficacy of Tezepelumab in Atopic
Dermatitis
Protocol Number: 20170755
EU Trial Number: EudraCT Number: 2018-001997-52
Other Identifiers: NCT03809663
Date of This 07 September 2021
Summary:
What does this summary cover?
This summary shows the main results from one clinical study. The results are only
for this study. Other studies may find different results. Researchers and health
authorities look at the results of many studies to decide which medicines work best
and are safest for participants.
Amgen has committed to make research results available to the public. This
summary has been provided as part of that commitment and should not be used for
any other purpose. It should not be considered to make a claim for any product or to
guide treatment decisions.